Details for New Drug Application (NDA): 021623
✉ Email this page to a colleague
The generic ingredient in SYNERA is lidocaine; tetracaine. There are twenty-nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the lidocaine; tetracaine profile page.
Summary for 021623
Tradename: | SYNERA |
Applicant: | Galen Specialty |
Ingredient: | lidocaine; tetracaine |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | PATCH;TOPICAL | Strength | 70MG;70MG | ||||
Approval Date: | Jun 23, 2005 | TE: | RLD: | Yes |
Expired US Patents for NDA 021623
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Galen Specialty | SYNERA | lidocaine; tetracaine | PATCH;TOPICAL | 021623-001 | Jun 23, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Galen Specialty | SYNERA | lidocaine; tetracaine | PATCH;TOPICAL | 021623-001 | Jun 23, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Galen Specialty | SYNERA | lidocaine; tetracaine | PATCH;TOPICAL | 021623-001 | Jun 23, 2005 | ⤷ Sign Up | ⤷ Sign Up |
Galen Specialty | SYNERA | lidocaine; tetracaine | PATCH;TOPICAL | 021623-001 | Jun 23, 2005 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription